Oxford, UK. GENinCode Plc (AIM: GENI), the polygenics company focused on the prevention of cardiovascular disease, announces the presentation by Kaiser Permanente, US on the ‘Utility of the CARDIO inCode-Score® CHD polygenic risk score for incident coronary heart disease interplay with lifestyle in a multi-ethnic cohort of more than 60,000 individuals’. The presentation was made at the Annual Meeting of

Premarket Notification 510(k) medical device filing for CARDIO inCode-Score (CIC-SCORE)   510(k) approval will enable US expansion and commercial distribution of CARDIO inCode-Score medical device   Oxford, UK. GENinCode Plc (AIM: GENI), the polygenics company focused on the prevention of cardiovascular disease (“CVD”), announces it has filed its Premarket Notification (510k) with the Food and Drug Administration (FDA) to expand its

MedStar to start clinical use of CARDIO inCode-Score® polygenic testing to prevent cardiovascular disease. Oxford, UK. GENinCode Plc (AIM: GENI), the predictive genetics company focused on the prevention of cardiovascular disease, announces its collaboration with MedStar Health (“MedStar”), a ten-hospital health system in the Washington, D.C. area, to use its CARDIO inCode-Score® (“CIC-SCORE”) test in primary care for the risk

MARKETING & BUSINESS DEVELOPMENT MANAGER-HYBRID ROLE-BARCELONA SPAIN-FULL TIME-UP TO € 65-75k + Bonus + Benefits (negotiable) We are a leading genetic testing organisation seeking an experienced Marketing & Business Develpment Manager   to join our team in GENinCode SLU (based in Barcelona) on a full time basis, with flexible working arrangements available. Working closely with the Group COO, the Marketing &

University Clinic in Dresden, Germany to commence testing Lipid inCode® polygenic testing to prevent Cardiovascular Disease Oxford, UK. GENinCode Plc (AIM: GENI), the predictive genetics company focused on the prevention of cardiovascular disease, announces today its collaboration with the University Clinic Dresden, Department of Internal Medicine and Department of Human Genetics, based in Dresden, Germany to use its Lipid inCode®

NHS earmarks budget to expand GENinCode’s LIPID inCode® polygenic testing to prevent Cardiovascular Disease Oxford, UK. GENinCode Plc (AIM: GENI), the genetics company focused on the prevention of cardiovascular disease, announces the expansion of its collaboration with the Academic Health Science Network for the North East and North Cumbria (“AHSN NENC”) to use the LIPID inCode® polygenic test in Primary

FULL TIME/PART TIME CLINICAL SCIENTIST  – GENETIC TESTING, IN-VITRO DIAGNOSTIC. SALARY NEG DEPENDANT UPON EXPERIENCE + BENEFITS We are a leading Genetic Testing organisation seeking an experienced Clinical Scientist  to join our team in Barcelona on a permanent, full time/part time basis, with flexible working patterns available. GENinCode is a Cutting-edge Biotech company specialized in Predictive  Genetics with a portfolio focused

Oxford, UK. GENinCode Plc (AIM: GENI), the genetics company focused on the prevention of cardiovascular disease (“CVD”), announces the Amercian Medical Asscoiation (AMA) grant of a Current Procedural Terminology (CPT) Proprietary Laboratory Analyses (PLA) code for its CARDIO inCode-SCORE (“CIC-SCORE”) polygenic test for the risk assessment of Coronary Heart Disease. The new code 0401U, has been approved and published by

First pilot test in Spanish Primary Care, resulting from an agreement between the Predictive Genetics company GENinCode and the Extremadura Public Healthcare, to improve cardiovascular disease (CVD) prevention. CARDIO inCode® is a world leading Personalised Medicine test, with significant scientific and clinical evidence which has been developed over the past 15 years and validated in over 80.000 patients. In 2019,

FULL / PART TIME (Neg) HCPC REGISTERED CLINICAL SCIENTIST (GENETICS)  – GENETIC TESTING, BIOTECH ORGANISATION, SALARY NEG DEPENDANT UPON EXPERIENCE + BENEFITS We are a leading Genetic Testing organisation seeking an experienced HCPC Registered Clinical Scientist (Genetics) to join our team on a permanent, Part-time or full-time basis (Neg).   THE ROLE HCPC registered Clinical Scientist. First or second-class BSc honours